Literature DB >> 27938824

The Global Burden of Disease Study and the Preventable Burden of NCD.

Catherine P Benziger1, Gregory A Roth1, Andrew E Moran2.   

Abstract

Noncommunicable diseases (NCD) now account for more than one-half of the global burden of disease. Cardiovascular diseases account for about one-half of NCD deaths, and the majority of cardiovascular disease deaths occur in low- and middle-income countries. The GBD (Global Burden of Disease) study measures and benchmarks health loss from death or disability from more than 300 diseases in over 100 countries. According to GBD analyses, the rise of NCD is in part due to increased life expectancy due to reduced premature mortality from communicable, child, and maternal illnesses, but preventable risk factors also contribute and present targets for NCD control efforts. In addition to traditional NCD risk factors, like tobacco smoking, high blood pressure, and unhealthful diet, nontraditional risk factors like air pollution and unhealthful alcohol consumption also play a role. The GBD study continues to grow by gathering more data from country partners than ever before, and by measuring health at the national and subnational levels and in smaller time increments. The GBD study will continue to provide the data to set priorities for and measure progress in the global effort to control the rising burden of NCD.
Copyright © 2016 World Heart Federation (Geneva). Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27938824     DOI: 10.1016/j.gheart.2016.10.024

Source DB:  PubMed          Journal:  Glob Heart


  116 in total

Review 1.  A critical review of assays for hazardous components of air pollution.

Authors:  Henry Jay Forman; Caleb Ellicott Finch
Journal:  Free Radic Biol Med       Date:  2018-01-31       Impact factor: 7.376

2.  Clusters of risk behaviors for noncommunicable diseases in the Brazilian adult population.

Authors:  Dyene Aparecida Silva; Ana Elisa Madalena Rinaldi; Catarina Machado Azeredo
Journal:  Int J Public Health       Date:  2019-05-06       Impact factor: 3.380

3.  A Telephone Surveillance System for Noncommunicable Diseases in Brazil.

Authors:  Carla C Enes; Luciana B Nucci
Journal:  Public Health Rep       Date:  2019-05-17       Impact factor: 2.792

Review 4.  Critical evaluation of causality assessment of herb-drug interactions in patients.

Authors:  Charles Awortwe; Memela Makiwane; Helmuth Reuter; Christo Muller; Johan Louw; Bernd Rosenkranz
Journal:  Br J Clin Pharmacol       Date:  2018-01-29       Impact factor: 4.335

5.  Experiences and Attitudes of International Travelers with Cardiovascular Disease: A Qualitative Analysis.

Authors:  Chee Hwui Liew; Gerard Thomas Flaherty
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 2.345

6.  Low-salt low-protein diet and blood pressure control in patients with advanced diabetic kidney disease and heavy proteinuria.

Authors:  Andreea Mihalache; Liliana Garneata; Carmen Antonia Mocanu; Tudor-Petrisor Simionescu; Gabriel Mircescu
Journal:  Int Urol Nephrol       Date:  2021-01-02       Impact factor: 2.370

Review 7.  Homocysteine-lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Mark Dayer
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

8.  Palmitate induces apoptotic cell death and inflammasome activation in human placental macrophages.

Authors:  Lisa M Rogers; Carlos H Serezani; Alison J Eastman; Alyssa H Hasty; Linda Englund-Ögge; Bo Jacobsson; Kasey C Vickers; David M Aronoff
Journal:  Placenta       Date:  2019-12-09       Impact factor: 3.481

9.  Perspective: Limiting Dependence on Nonrandomized Studies and Improving Randomized Trials in Human Nutrition Research: Why and How.

Authors:  John F Trepanowski; John P A Ioannidis
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

Review 10.  Kuanxiong Aerosol () in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology.

Authors:  Yu-Zhuo Zhang; Rui-Xiang Zeng; Yuan-Shen Zhou; Min-Zhou Zhang
Journal:  Chin J Integr Med       Date:  2021-05-28       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.